General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management.
This report aims to provide a comprehensive presentation of the global market for General Anesthesia Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding General Anesthesia Drugs. This report contains market size and forecasts of General Anesthesia Drugs in global, including the following market information:
- Global General Anesthesia Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
- Global General Anesthesia Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five General Anesthesia Drugs companies in 2022 (%)
The global General Anesthesia Drugs market was valued at US$ 7742.8 million in 2022 and is projected to reach US$ 9256.7 million by 2029, at a CAGR of 2.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The major players in global General Anesthesia Drugs market include Astrazeneca, Fresenius-Kabi, B.Braun, etc. The top 3 players occupy about 40% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. Propofol is the main type, with a share about 30%. Intravenous Anesthetics is the main application, which holds a share about 70%.
We surveyed the General Anesthesia Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global General Anesthesia Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global General Anesthesia Drugs Market Segment Percentages, by Type, 2022 (%)
- Propofol
- Etomidate
- Midazolam
- Sevoflurane
- Isoflurane
- Others
Global General Anesthesia Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global General Anesthesia Drugs Market Segment Percentages, by Application, 2022 (%)
- Intravenous Anesthetics
- Inhalational Anesthetics
Global General Anesthesia Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global General Anesthesia Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies General Anesthesia Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies General Anesthesia Drugs revenues share in global market, 2022 (%)
- Key companies General Anesthesia Drugs sales in global market, 2018-2023 (Estimated), (K Units)
- Key companies General Anesthesia Drugs sales share in global market, 2022 (%)
- Further, the report presents profiles of competitors in the market, key players include:
- Astrazeneca
- Fresenius-Kabi
- AbbVie
- Baxter Healthcare
- B.Braun
- Maruishi
- Piramal
- Hikma Pharmaceuticals
- Mylan
- Nhwa
- Hengrui
- Lunan
- Outline of Major Chapters:
- Chapter 1: Introduces the definition of General Anesthesia Drugs, market overview.
- Chapter 2: Global General Anesthesia Drugs market size in revenue and volume.
- Chapter 3: Detailed analysis of General Anesthesia Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of General Anesthesia Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: Global General Anesthesia Drugs capacity by region & country.
- Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
- Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
- Chapter 11: The main points and conclusions of the report.
